Live Breaking News & Updates on Post Operative Pain Relief

Stay updated with breaking news from Post operative pain relief. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DURECT Corporation Announces Second Quarter 2021 Financial Results and Update of Programs

DURECT Corporation Announces Second Quarter 2021 Financial Results and Update of Programs
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Jamese Brown , Human Services , Drug Administration , Company Epigenetic Regulator Program , Exchange Commission , Epigenetic Regulator Program , Journal Of Lipid Research , Us Department Of Health , International Liver Conference , Corporation Nasdaq , Agency For Healthcare Research , Clinical Development , Therapeutic Targets Virtual Summit , Selected Programs , Track Designation , Therapeutic Targets Virtual , Healthcare Research , Alcoholic Steatohepatitis , Liver Conference , Post Operative Pain Relief , Prescribing Information , Boxed Warning , Oxford Finance , Fast Track Designation , Looking Statement ,

DURECT Corporation Announces Second Quarter 2021 Financial Results and Update of Programs

DURECT Corporation Announces Second Quarter 2021 Financial Results and Update of Programs
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Jamese Brown , Human Services , Drug Administration , Company Epigenetic Regulator Program , Exchange Commission , Epigenetic Regulator Program , Journal Of Lipid Research , Us Department Of Health , International Liver Conference , Corporation Nasdaq , Agency For Healthcare Research , Clinical Development , Therapeutic Targets Virtual Summit , Selected Programs , Track Designation , Therapeutic Targets Virtual , Healthcare Research , Alcoholic Steatohepatitis , Liver Conference , Post Operative Pain Relief , Prescribing Information , Boxed Warning , Oxford Finance , Fast Track Designation , Looking Statement ,

DURECT Corporation Announces First Quarter 2021 Financial Results and Update of Programs

DURECT Corporation Announces First Quarter 2021 Financial Results and Update of Programs
Webcast of Earnings Call Today, May 4th at 4:30 p.m. ET
News provided by
Share this article
Share this article
CUPERTINO, Calif., May 4, 2021 /PRNewswire/ DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended March 31, 2021 and provided a corporate update.
Q1 2021 Accomplishments:
Initiated patient dosing in the Phase 2b AHFIRM clinical study of DUR-928 in severe Alcohol-associated Hepatitis (AH)
FDA approval of POSIMIR in adults to produce post-surgical analgesia for up to 72 hours following Arthroscopic Subacromial Decompression
Publication of DUR-928 s mechanism of action
Appointment of two highly experienced biopharmaceutical board members ....

United States , Jamese Brown , Human Services , Drug Administration , Company Epigenetic Regulator Program , Exchange Commission , Epigenetic Regulator Program , Journal Of Lipid Research , Us Department Of Health , Corporation Nasdaq , Agency For Healthcare Research , Clinical Development , Alcohol Associated Hepatitis , Arthroscopic Subacromial Decompression , Selected Programs , Track Designation , Fast Track Designation , Healthcare Research , Alcoholic Steatohepatitis , Post Operative Pain Relief , Prescribing Information , Boxed Warning , Eastern Time , Looking Statement , Fast Track , ஒன்றுபட்டது மாநிலங்களில் ,